In high-burden settings, the nomogram variables (RBC, ALB, NLR) could optimize resource use through two-stage screening—initial IGRA followed by targeted molecular testing for high-risk cases, aligning with WHO guidelines on active TB diagnosis [27]. This evidence concerns the gene ALB and tuberculosis.